Cerus Corporation

CERS ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $13.7M $22.6M $71.0M $22.8M $29.5M $26.7M $25.5M $28.9M
Accounts Receivable $12.4M $6.9M $5.8M $5.5M $6.1M $4.4M $6.1M $4.8M
Inventory $14.5M $12.5M $10.8M $15.0M $13.1M $10.2M $6.4M $6.0M
Total Current Assets $89.9M $94.1M $130.4M $74.9M $78.2M $44.0M $39.7M $41.8M
Property, Plant & Equipment $2.1M $3.0M $3.5M $3.8M $2.2M $1.7M $2.0M $2.4M
Goodwill $1.3M $1.3M $1.3M $1.3M $1.3M $1.3M $1.3M $1.3M
Intangible Assets (Excl. Goodwill) $536.0K $738.0K $940.0K $1.1M $1.3M $1.5M $1.7M $2.0M
Total Assets $98.2M $103.5M $139.4M $81.8M $83.4M $48.9M $45.4M $48.2M
Liabilities
Accounts Payable $11.0M $8.6M $5.2M $9.9M $5.7M $7.2M $4.7M $3.2M
Total Current Liabilities $23.1M $26.9M $21.9M $29.2M $39.4M $25.6M $21.1M $19.7M
Long-Term Debt — — $20.0M $10.0M — — — —
Total Liabilities $59.3M $45.7M $44.6M $40.3M $40.6M $29.8M $27.1M $24.4M
Stockholders' Equity
Retained Earnings $-721.3M $-660.7M $-597.8M $-541.9M $-503.2M $-459.9M $-443.9M $-427.0M
Total Stockholders' Equity $38.9M $57.8M $94.8M $41.5M $42.8M $19.1M $18.3M $23.7M
← Newer Page 2 of 2 Older →